Limitations of Widely Used High-Risk Human Papillomavirus Laboratory-Developed Testing in Cervical Cancer Screening

Drug, Healthcare and Patient Safety - New Zealand
doi 10.2147/dhps.s41886
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Primary High-Risk Human Papillomavirus Testing for Cervical Cancer Screening in the United States: Is It Time?

Archives of Pathology and Laboratory Medicine
MedicineForensic MedicinePathologyMedical Laboratory Technology
2018English

High‐risk Human Papillomavirus Test a Good Option for Cervical Cancer Screening

Cancer
Cancer ResearchOncology
2018English

Improved Rates of Cervical Cancer Screening Among Transmasculine Patients Through Self-Collected Swabs for High-Risk Human Papillomavirus DNA Testing

Transgender Health
MedicineGender Studies
2020English

High-Risk Human Papillomavirus in HIV-infected Women Undergoing Cervical Cancer Screening in Lilongwe, Malawi: A Pilot Study

International Journal of STD and AIDS
PharmacologyPublic HealthEnvironmentalDermatologyInfectious DiseasesOccupational Health
2014English

By How Much Could Screening by Primary Human Papillomavirus Testing Reduce Cervical Cancer Incidence in England?

Journal of Medical Screening
Health PolicyPublic HealthOccupational HealthEnvironmental
2016English

Long Term Predictive Values of Cytology and Human Papillomavirus Testing in Cervical Cancer Screening: Joint European Cohort Study

BMJ
2008English

Human Papillomavirus and Cervical Cancer

Emerging Infectious Diseases
EpidemiologyInfectious DiseasesMicrobiology
2004English

Human Papillomavirus Testing in Primary Screening for the Detection of High-Grade Cervical Lesions: A Study of 7932 Women

British Journal of Cancer
Cancer ResearchOncology
2001English

Utilization of Human Papillomavirus Testing for Cervical Cancer Prevention in a University Hospital

Cadernos de Saude Publica
MedicineEnvironmentalPublic HealthOccupational Health
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy